Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15825018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 64-year-old woman with a mechanical mitral valve prosthesis developed late-onset Candida endocarditis. Blood cultures grew Candida glabrata and Candida krusei. Transesophageal echocardiography demonstrated vegetations on the valve. The patient was not medically fit for valve replacement, but her condition was successfully treated with 6 weeks of intravenous caspofungin therapy.
Medical subject headings
- Antifungal Agents
- Candidiasis
- Endocarditis
- Heart Valve Prosthesis
- Peptides, Cyclic